Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making

Acute stress can exert beneficial or detrimental effects on different forms of cognition. In the present study, we assessed the effects of acute restraint stress on different forms of cost/benefit decision-making, and some of the hormonal and neurochemical mechanisms that may underlie these effects....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychopharmacology (New York, N.Y.) N.Y.), 2012-09, Vol.37 (10), p.2194-2209
Hauptverfasser: SHAFIEI, Naghmeh, GRAY, Megan, VIAU, Victor, FLORESCO, Stan B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2209
container_issue 10
container_start_page 2194
container_title Neuropsychopharmacology (New York, N.Y.)
container_volume 37
creator SHAFIEI, Naghmeh
GRAY, Megan
VIAU, Victor
FLORESCO, Stan B
description Acute stress can exert beneficial or detrimental effects on different forms of cognition. In the present study, we assessed the effects of acute restraint stress on different forms of cost/benefit decision-making, and some of the hormonal and neurochemical mechanisms that may underlie these effects. Effort-based decision-making was assessed where rats chose between a low effort/reward (1 press=2 pellets) or high effort/reward option (4 pellets), with the effort requirement increasing over 4 blocks of trials (2, 5, 10, and 20 lever presses). Restraint stress for 1 h decreased preference for the more costly reward and induced longer choice latencies. Control experiments revealed that the effects on decision-making were not mediated by general reductions in motivation or preference for larger rewards. In contrast, acute stress did not affect delay-discounting, when rats chose between a small/immediate vs larger/delayed reward. The effects of stress on decision-making were not mimicked by treatment with physiological doses of corticosterone (1-3 mg/kg). Blockade of dopamine receptors with flupenthixol (0.25 mg/kg) before restraint did not attenuate stress-induced effects on effort-related choice, but abolished effects on choice latencies. These data suggest that acute stress interferes somewhat selectively with cost/benefit evaluations concerning effort costs. These effects do not appear to be mediated solely by enhanced glucocorticoid activity, whereas dopaminergic activation may contribute to increased deliberation times induced by stress. These findings may provide insight into impairments in decision-making and anergia associated with stress-related disorders, such as depression.
doi_str_mv 10.1038/npp.2012.69
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3422485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1038606225</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-70ebfbe42216bb6ad4640741e3a35dce7e362a8c5430132b78bf9cf6848e812d3</originalsourceid><addsrcrecordid>eNqNkc1PGzEQxa0KVAL0xB2thCpVQhv8vd4LUpryVYE40ErcLK8zC6Ybb2p7I_Hf14EUSk-c5jC_eTPzHkJ7BI8JZurILxZjigkdy_oDGpGK41IyfruBRljVrCSM3W6h7RgfMCaikuoj2qJUyFpgOULfJ3ZIUNykADEWF342WIjFDXRgk1tCMekSBJNc72PhfDHtYzr6Ch5al4pvYF3MnfLK_HL-bhdttqaL8Gldd9DP05Mf0_Py8vrsYjq5LC2vaCorDE3bAKeUyKaRZsYlxxUnwAwTMwsVMEmNsoIzTBhtKtW0tW2l4goUoTO2g46fdRdDM4c84VMwnV4ENzfhUffG6bcd7-71Xb_ULO_kSmSBL2uB0P8eICY9d9FC1xkP_RD1ylWJZTbpPSgXhEtcZ_TgP_ShH4LPTqwoJgSvBM3U4TNlQx9jgPblboKfFuscp17FqeVKc__fV1_Yv_ll4PMaMNGarg3G50xeOcmIwjVlfwCRkaeC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1033554752</pqid></control><display><type>article</type><title>Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>SHAFIEI, Naghmeh ; GRAY, Megan ; VIAU, Victor ; FLORESCO, Stan B</creator><creatorcontrib>SHAFIEI, Naghmeh ; GRAY, Megan ; VIAU, Victor ; FLORESCO, Stan B</creatorcontrib><description>Acute stress can exert beneficial or detrimental effects on different forms of cognition. In the present study, we assessed the effects of acute restraint stress on different forms of cost/benefit decision-making, and some of the hormonal and neurochemical mechanisms that may underlie these effects. Effort-based decision-making was assessed where rats chose between a low effort/reward (1 press=2 pellets) or high effort/reward option (4 pellets), with the effort requirement increasing over 4 blocks of trials (2, 5, 10, and 20 lever presses). Restraint stress for 1 h decreased preference for the more costly reward and induced longer choice latencies. Control experiments revealed that the effects on decision-making were not mediated by general reductions in motivation or preference for larger rewards. In contrast, acute stress did not affect delay-discounting, when rats chose between a small/immediate vs larger/delayed reward. The effects of stress on decision-making were not mimicked by treatment with physiological doses of corticosterone (1-3 mg/kg). Blockade of dopamine receptors with flupenthixol (0.25 mg/kg) before restraint did not attenuate stress-induced effects on effort-related choice, but abolished effects on choice latencies. These data suggest that acute stress interferes somewhat selectively with cost/benefit evaluations concerning effort costs. These effects do not appear to be mediated solely by enhanced glucocorticoid activity, whereas dopaminergic activation may contribute to increased deliberation times induced by stress. These findings may provide insight into impairments in decision-making and anergia associated with stress-related disorders, such as depression.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/npp.2012.69</identifier><identifier>PMID: 22569506</identifier><identifier>CODEN: NEROEW</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Animals ; Anti-Inflammatory Agents - pharmacology ; Biological and medical sciences ; Brain research ; Cognition ; Cognition &amp; reasoning ; Corticosterone ; Corticosterone - pharmacology ; Cost-Benefit Analysis ; Costs ; Data processing ; Decision making ; Decision Making - drug effects ; Decision Making - physiology ; Depression ; Dopamine ; Dopamine - physiology ; Dopamine Antagonists - pharmacology ; Dopamine receptors ; Flupenthixol ; Flupenthixol - pharmacology ; Glucocorticoids ; Glucocorticoids - physiology ; Male ; Medical sciences ; Motivation ; Original ; Physiology ; Rats ; Rats, Long-Evans ; Reinforcement ; Restraint, Physical ; Reward ; Stress ; Stress, Psychological - metabolism ; Stress, Psychological - physiopathology</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2012-09, Vol.37 (10), p.2194-2209</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Sep 2012</rights><rights>Copyright © 2012 American College of Neuropsychopharmacology 2012 American College of Neuropsychopharmacology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-70ebfbe42216bb6ad4640741e3a35dce7e362a8c5430132b78bf9cf6848e812d3</citedby><cites>FETCH-LOGICAL-c472t-70ebfbe42216bb6ad4640741e3a35dce7e362a8c5430132b78bf9cf6848e812d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422485/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422485/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,724,777,781,882,27906,27907,53773,53775</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=26318092$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22569506$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SHAFIEI, Naghmeh</creatorcontrib><creatorcontrib>GRAY, Megan</creatorcontrib><creatorcontrib>VIAU, Victor</creatorcontrib><creatorcontrib>FLORESCO, Stan B</creatorcontrib><title>Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>Acute stress can exert beneficial or detrimental effects on different forms of cognition. In the present study, we assessed the effects of acute restraint stress on different forms of cost/benefit decision-making, and some of the hormonal and neurochemical mechanisms that may underlie these effects. Effort-based decision-making was assessed where rats chose between a low effort/reward (1 press=2 pellets) or high effort/reward option (4 pellets), with the effort requirement increasing over 4 blocks of trials (2, 5, 10, and 20 lever presses). Restraint stress for 1 h decreased preference for the more costly reward and induced longer choice latencies. Control experiments revealed that the effects on decision-making were not mediated by general reductions in motivation or preference for larger rewards. In contrast, acute stress did not affect delay-discounting, when rats chose between a small/immediate vs larger/delayed reward. The effects of stress on decision-making were not mimicked by treatment with physiological doses of corticosterone (1-3 mg/kg). Blockade of dopamine receptors with flupenthixol (0.25 mg/kg) before restraint did not attenuate stress-induced effects on effort-related choice, but abolished effects on choice latencies. These data suggest that acute stress interferes somewhat selectively with cost/benefit evaluations concerning effort costs. These effects do not appear to be mediated solely by enhanced glucocorticoid activity, whereas dopaminergic activation may contribute to increased deliberation times induced by stress. These findings may provide insight into impairments in decision-making and anergia associated with stress-related disorders, such as depression.</description><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Brain research</subject><subject>Cognition</subject><subject>Cognition &amp; reasoning</subject><subject>Corticosterone</subject><subject>Corticosterone - pharmacology</subject><subject>Cost-Benefit Analysis</subject><subject>Costs</subject><subject>Data processing</subject><subject>Decision making</subject><subject>Decision Making - drug effects</subject><subject>Decision Making - physiology</subject><subject>Depression</subject><subject>Dopamine</subject><subject>Dopamine - physiology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Dopamine receptors</subject><subject>Flupenthixol</subject><subject>Flupenthixol - pharmacology</subject><subject>Glucocorticoids</subject><subject>Glucocorticoids - physiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Motivation</subject><subject>Original</subject><subject>Physiology</subject><subject>Rats</subject><subject>Rats, Long-Evans</subject><subject>Reinforcement</subject><subject>Restraint, Physical</subject><subject>Reward</subject><subject>Stress</subject><subject>Stress, Psychological - metabolism</subject><subject>Stress, Psychological - physiopathology</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkc1PGzEQxa0KVAL0xB2thCpVQhv8vd4LUpryVYE40ErcLK8zC6Ybb2p7I_Hf14EUSk-c5jC_eTPzHkJ7BI8JZurILxZjigkdy_oDGpGK41IyfruBRljVrCSM3W6h7RgfMCaikuoj2qJUyFpgOULfJ3ZIUNykADEWF342WIjFDXRgk1tCMekSBJNc72PhfDHtYzr6Ch5al4pvYF3MnfLK_HL-bhdttqaL8Gldd9DP05Mf0_Py8vrsYjq5LC2vaCorDE3bAKeUyKaRZsYlxxUnwAwTMwsVMEmNsoIzTBhtKtW0tW2l4goUoTO2g46fdRdDM4c84VMwnV4ENzfhUffG6bcd7-71Xb_ULO_kSmSBL2uB0P8eICY9d9FC1xkP_RD1ylWJZTbpPSgXhEtcZ_TgP_ShH4LPTqwoJgSvBM3U4TNlQx9jgPblboKfFuscp17FqeVKc__fV1_Yv_ll4PMaMNGarg3G50xeOcmIwjVlfwCRkaeC</recordid><startdate>20120901</startdate><enddate>20120901</enddate><creator>SHAFIEI, Naghmeh</creator><creator>GRAY, Megan</creator><creator>VIAU, Victor</creator><creator>FLORESCO, Stan B</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120901</creationdate><title>Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making</title><author>SHAFIEI, Naghmeh ; GRAY, Megan ; VIAU, Victor ; FLORESCO, Stan B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-70ebfbe42216bb6ad4640741e3a35dce7e362a8c5430132b78bf9cf6848e812d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Brain research</topic><topic>Cognition</topic><topic>Cognition &amp; reasoning</topic><topic>Corticosterone</topic><topic>Corticosterone - pharmacology</topic><topic>Cost-Benefit Analysis</topic><topic>Costs</topic><topic>Data processing</topic><topic>Decision making</topic><topic>Decision Making - drug effects</topic><topic>Decision Making - physiology</topic><topic>Depression</topic><topic>Dopamine</topic><topic>Dopamine - physiology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Dopamine receptors</topic><topic>Flupenthixol</topic><topic>Flupenthixol - pharmacology</topic><topic>Glucocorticoids</topic><topic>Glucocorticoids - physiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Motivation</topic><topic>Original</topic><topic>Physiology</topic><topic>Rats</topic><topic>Rats, Long-Evans</topic><topic>Reinforcement</topic><topic>Restraint, Physical</topic><topic>Reward</topic><topic>Stress</topic><topic>Stress, Psychological - metabolism</topic><topic>Stress, Psychological - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SHAFIEI, Naghmeh</creatorcontrib><creatorcontrib>GRAY, Megan</creatorcontrib><creatorcontrib>VIAU, Victor</creatorcontrib><creatorcontrib>FLORESCO, Stan B</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SHAFIEI, Naghmeh</au><au>GRAY, Megan</au><au>VIAU, Victor</au><au>FLORESCO, Stan B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2012-09-01</date><risdate>2012</risdate><volume>37</volume><issue>10</issue><spage>2194</spage><epage>2209</epage><pages>2194-2209</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><coden>NEROEW</coden><abstract>Acute stress can exert beneficial or detrimental effects on different forms of cognition. In the present study, we assessed the effects of acute restraint stress on different forms of cost/benefit decision-making, and some of the hormonal and neurochemical mechanisms that may underlie these effects. Effort-based decision-making was assessed where rats chose between a low effort/reward (1 press=2 pellets) or high effort/reward option (4 pellets), with the effort requirement increasing over 4 blocks of trials (2, 5, 10, and 20 lever presses). Restraint stress for 1 h decreased preference for the more costly reward and induced longer choice latencies. Control experiments revealed that the effects on decision-making were not mediated by general reductions in motivation or preference for larger rewards. In contrast, acute stress did not affect delay-discounting, when rats chose between a small/immediate vs larger/delayed reward. The effects of stress on decision-making were not mimicked by treatment with physiological doses of corticosterone (1-3 mg/kg). Blockade of dopamine receptors with flupenthixol (0.25 mg/kg) before restraint did not attenuate stress-induced effects on effort-related choice, but abolished effects on choice latencies. These data suggest that acute stress interferes somewhat selectively with cost/benefit evaluations concerning effort costs. These effects do not appear to be mediated solely by enhanced glucocorticoid activity, whereas dopaminergic activation may contribute to increased deliberation times induced by stress. These findings may provide insight into impairments in decision-making and anergia associated with stress-related disorders, such as depression.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>22569506</pmid><doi>10.1038/npp.2012.69</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-133X
ispartof Neuropsychopharmacology (New York, N.Y.), 2012-09, Vol.37 (10), p.2194-2209
issn 0893-133X
1740-634X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3422485
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Animals
Anti-Inflammatory Agents - pharmacology
Biological and medical sciences
Brain research
Cognition
Cognition & reasoning
Corticosterone
Corticosterone - pharmacology
Cost-Benefit Analysis
Costs
Data processing
Decision making
Decision Making - drug effects
Decision Making - physiology
Depression
Dopamine
Dopamine - physiology
Dopamine Antagonists - pharmacology
Dopamine receptors
Flupenthixol
Flupenthixol - pharmacology
Glucocorticoids
Glucocorticoids - physiology
Male
Medical sciences
Motivation
Original
Physiology
Rats
Rats, Long-Evans
Reinforcement
Restraint, Physical
Reward
Stress
Stress, Psychological - metabolism
Stress, Psychological - physiopathology
title Acute Stress Induces Selective Alterations in Cost/Benefit Decision-Making
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T09%3A11%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Stress%20Induces%20Selective%20Alterations%20in%20Cost/Benefit%20Decision-Making&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=SHAFIEI,%20Naghmeh&rft.date=2012-09-01&rft.volume=37&rft.issue=10&rft.spage=2194&rft.epage=2209&rft.pages=2194-2209&rft.issn=0893-133X&rft.eissn=1740-634X&rft.coden=NEROEW&rft_id=info:doi/10.1038/npp.2012.69&rft_dat=%3Cproquest_pubme%3E1038606225%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1033554752&rft_id=info:pmid/22569506&rfr_iscdi=true